Skip to main content
# Title Department Research Member Research Year
461 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
462 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Clinical Pathology Dr. Noha gaber sayed 2019
463 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
464 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
465 Sensitvity of flowcytometry immunphenotyping compared to Bone marrow morphology in diagnosis of multiple myeloma Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2019
466 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
467 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
468 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
469 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
Department of Pathology Amira Emad Mohamed Elwy 2019
470 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019